Literature DB >> 35085484

ICAM-1-mediated adhesion is a prerequisite for exosome-induced T cell suppression.

Wei Zhang1, Wenqun Zhong1, Beike Wang1, Jiegang Yang1, Jingbo Yang1, Ziyan Yu1, Zhiyuan Qin1, Alex Shi1, Wei Xu2, Cathy Zheng2, Lynn M Schuchter2, Giorgos C Karakousis3, Tara C Mitchell2, Ravi Amaravadi2, Meenhard Herlyn4, Haidong Dong5, Phyllis A Gimotty6, George Daaboul7, Xiaowei Xu8, Wei Guo9.   

Abstract

Tumor-derived extracellular vesicles (TEVs) suppress the proliferation and cytotoxicity of CD8+ T cells, thereby contributing to tumor immune evasion. Here, we report that the adhesion molecule intercellular adhesion molecule 1 (ICAM-1) co-localizes with programmed death ligand 1 (PD-L1) on the exosomes; both ICAM-1 and PD-L1 are upregulated by interferon-γ. Exosomal ICAM-1 interacts with LFA-1, which is upregulated in activated T cells. Blocking ICAM-1 on TEVs reduces the interaction of TEVs with CD8+ T cells and attenuates PD-L1-mediated suppressive effects of TEVs. During this study, we have established an extracellular vesicle-target cell interaction detection through SorTagging (ETIDS) system to assess the interaction between a TEV ligand and its target cell receptor. Using this system, we demonstrate that the interaction of TEV PD-L1 with programmed cell death 1 (PD-1) on T cells is significantly reduced in the absence of ICAM-1. Our study demonstrates that ICAM-1-LFA-1-mediated adhesion between TEVs and T cells is a prerequisite for exosomal PD-L1-mediated immune suppression.
Copyright © 2022 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CD8(+) T cells; ICAM-1; PD-L1; exosome; extracellular vesicles; immune suppression

Mesh:

Substances:

Year:  2022        PMID: 35085484      PMCID: PMC8881799          DOI: 10.1016/j.devcel.2022.01.002

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  52 in total

Review 1.  The biology, function, and biomedical applications of exosomes.

Authors:  Raghu Kalluri; Valerie S LeBleu
Journal:  Science       Date:  2020-02-07       Impact factor: 47.728

2.  Human tumor-derived exosomes (TEX) regulate Treg functions via cell surface signaling rather than uptake mechanisms.

Authors:  Laurent Muller; Patricia Simms; Chang-Sook Hong; Michael I Nishimura; Edwin K Jackson; Simon C Watkins; Theresa L Whiteside
Journal:  Oncoimmunology       Date:  2017-07-19       Impact factor: 8.110

3.  ICAM-1 on exosomes from mature dendritic cells is critical for efficient naive T-cell priming.

Authors:  Elodie Segura; Carole Nicco; Bérangère Lombard; Philippe Véron; Graça Raposo; Frédéric Batteux; Sebastian Amigorena; Clotilde Théry
Journal:  Blood       Date:  2005-03-24       Impact factor: 22.113

4.  Clinical Significance of PD-L1+ Exosomes in Plasma of Head and Neck Cancer Patients.

Authors:  Marie-Nicole Theodoraki; Saigopalakrishna S Yerneni; Thomas K Hoffmann; William E Gooding; Theresa L Whiteside
Journal:  Clin Cancer Res       Date:  2017-12-12       Impact factor: 12.531

5.  Rab27a and Rab27b control different steps of the exosome secretion pathway.

Authors:  Matias Ostrowski; Nuno B Carmo; Sophie Krumeich; Isabelle Fanget; Graça Raposo; Ariel Savina; Catarina F Moita; Kristine Schauer; Alistair N Hume; Rui P Freitas; Bruno Goud; Philippe Benaroch; Nir Hacohen; Mitsunori Fukuda; Claire Desnos; Miguel C Seabra; François Darchen; Sebastian Amigorena; Luis F Moita; Clotilde Thery
Journal:  Nat Cell Biol       Date:  2009-12-06       Impact factor: 28.824

6.  Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells.

Authors:  Adrian E Morelli; Adriana T Larregina; William J Shufesky; Mara L G Sullivan; Donna Beer Stolz; Glenn D Papworth; Alan F Zahorchak; Alison J Logar; Zhiliang Wang; Simon C Watkins; Louis D Falo; Angus W Thomson
Journal:  Blood       Date:  2004-07-29       Impact factor: 22.113

Review 7.  Top 10 Challenges in Cancer Immunotherapy.

Authors:  Priti S Hegde; Daniel S Chen
Journal:  Immunity       Date:  2020-01-14       Impact factor: 31.745

8.  Induction of ICAM-1 and HLA-DR expression by IFN-gamma in malignant melanoma cell lines.

Authors:  J D Kim; J L Lee; J H Park; J M Lee; Y H Kim; S J Kim
Journal:  Yonsei Med J       Date:  1995-03       Impact factor: 2.759

Review 9.  Exosomes: Mechanisms of Uptake.

Authors:  Kelly J McKelvey; Katie L Powell; Anthony W Ashton; Jonathan M Morris; Sharon A McCracken
Journal:  J Circ Biomark       Date:  2015-07-17

Review 10.  The immunological synapse.

Authors:  Michael L Dustin
Journal:  Arthritis Res       Date:  2002-05-09
View more
  3 in total

Review 1.  Small extracellular vesicle PD-L1 in cancer: the knowns and unknowns.

Authors:  Zi-Li Yu; Jin-Yuan Liu; Gang Chen
Journal:  NPJ Precis Oncol       Date:  2022-06-21

Review 2.  Liquid Biopsy in Pre-Metastatic Niche: From Molecular Mechanism to Clinical Application.

Authors:  Zaoqu Liu; Ying Kong; Qin Dang; Siyuan Weng; Youyang Zheng; Yuqing Ren; Jinxiang Lv; Na Li; Yilin Han; Xinwei Han
Journal:  Front Immunol       Date:  2022-07-15       Impact factor: 8.786

Review 3.  Mechanisms of extracellular vesicle-mediated immune evasion in melanoma.

Authors:  Lothar C Dieterich
Journal:  Front Immunol       Date:  2022-08-23       Impact factor: 8.786

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.